Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Neurochem. 2012 Mar 14;121(3):486–494. doi: 10.1111/j.1471-4159.2012.07699.x

Table 2.

Levels of catalytic subunits of s-20S and i-20S in EAE (pmol/mg protein)

Control young Acute EAE Control old Chronic EAE
β1 1.73 ± 0.20 1.99 ± 0.11 1.70 ± 0.14 1.17 ± 0.05*
β2 0.95 ± 0.10 0.78 ± 0.16 0.49 ± 0.05 0.59 ± 0.30
β5 1.57 ± 0.10 1.55 ± 0.06 1.25 ± 0.24 0.41 ± 0.10*
iβ1 0.99 ± 0.30 2.37 ± 0.20* 0.89 ± 0.09 0.72 ± 0.13
iβ2 2.03 ± 0.49 3.59 ± 0.50* 1.45 ± 0.08 1.04 ± 0.22
iβ5 0.92 ± 0.06 1.69 ± 0.26* 0.86 ± 0.07 1.02 ± 0.23

The concentration of each standard and immuno catalytic subunit in control and EAE cerebella was determined by western blot analysis (Fig. 1 and 2) using calibration curves made with increasing amounts of either purified standard proteasome or immunoproteasome. Values are the mean ± SEM of 3 animals per experimental group. Asterisks denote values that are significantly different (p<0.05) from control.